Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.

Literature DB >> 18180883

X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.

Donn M Stewart¹, Lan Tian, Luigi D Notarangelo, David L Nelson.

Abstract

X-linked hypogammaglobulinemia and isolated growth hormone deficiency (XLH-GHD, OMIM # 307200) is a primary immunodeficiency disorder characterized by pan-hypogammaglobulinemia and isolated growth hormone deficiency. The disease, which is only known to occur in a single family, shares many features with X-linked agammaglobulinemia (XLA, OMIM # 300300). The current review summarizes the clinical, laboratory, and genetic features of the disease as they have unfolded over the past quarter-century since its description.

Entities: Chemical

Mesh：

Substances：

Year: 2008 PMID： 18180883 DOI： 10.1007/s12026-007-0028-9

Source DB: PubMed Journal: Immunol Res ISSN： 0257-277X Impact factor: 4.505

29 in total

1. RefSeq and LocusLink: NCBI gene-centered resources.

Authors: K D Pruitt; D R Maglott
Journal: Nucleic Acids Res Date: 2001-01-01 Impact factor: 16.971

2. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia.

Authors: C M Wilfert; R H Buckley; T Mohanakumar; J F Griffith; S L Katz; J K Whisnant; P A Eggleston; M Moore; E Treadwell; M N Oxman; F S Rosen
Journal: N Engl J Med Date: 1977-06-30 Impact factor: 91.245

3. A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors: C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal: Nature Date: 1996-03-14 Impact factor: 49.962

4. X-linked hypogammaglobulinemia and isolated growth hormone deficiency.

Authors: T A Fleisher; R M White; S Broder; S P Nissley; R M Blaese; J J Mulvihill; G Olive; T A Waldmann
Journal: N Engl J Med Date: 1980-06-26 Impact factor: 91.245

5. Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition.

Authors: T Kouro; K Nagata; S Takaki; S Nisitani; M Hirano; M I Wahl; O N Witte; H Karasuyama; K Takatsu
Journal: Int Immunol Date: 2001-04 Impact factor: 4.823

6. Colorectal cancer in patients with X-linked agammaglobulinaemia.

Authors: J W van der Meer; R S Weening; P T Schellekens; I P van Munster; F M Nagengast
Journal: Lancet Date: 1993-06-05 Impact factor: 79.321

7. X-linked agammaglobulinemia and gastric adenocarcinoma.

Authors: P Lavilla; A Gil; M C Rodríguez; M L Dupla; V Pintado; G Fontán
Journal: Cancer Date: 1993-09-01 Impact factor: 6.860

8. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors: D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal: Nature Date: 1993-01-21 Impact factor: 49.962

9. Lymphocyte analysis in a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency after development of echovirus dermatomyositis and meningoencephalitis.

Authors: D K Wagner; G E Marti; E S Jaffe; S E Straus; D L Nelson; T A Fleisher
Journal: Int Arch Allergy Appl Immunol Date: 1989

X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.

1. RefSeq and LocusLink: NCBI gene-centered resources.

2. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia.

3. A comprehensive genetic map of the human genome based on 5,264 microsatellites.

4. X-linked hypogammaglobulinemia and isolated growth hormone deficiency.

5. Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition.

6. Colorectal cancer in patients with X-linked agammaglobulinaemia.

7. X-linked agammaglobulinemia and gastric adenocarcinoma.

8. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

9. Lymphocyte analysis in a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency after development of echovirus dermatomyositis and meningoencephalitis.

10. Regulation of an early developmental checkpoint in the B cell pathway by Ig beta.

1. HIPK2 is necessary for type I interferon-mediated antiviral immunity.

2. Infectious diseases and immunological responses in adult subjects with lifetime untreated, congenital GH deficiency.

Review 3. Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).

Review 4. Genetic causes and treatment of isolated growth hormone deficiency-an update.

Review 5. Growth hormone - past, present and future.

Review 6. Roles and regulations of the ETS transcription factor ELF4/MEF.

7. Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report.